Summit-based life sciences company Celgene Corp. announced today it is repurchasing $600 million in shares of its common stock through an accelerated repurchase agreement with an investment bank.

Merck & Co., in the Whitehouse Station section of Readington, announced today an agreement with Samsung Bioepis Co. Ltd. to develop and commercialize several biosimilar candidates.

Savient Pharmaceuticals Inc., in Bridgewater, announced today it is partnering with Sobi, of Stockholm, to promote Kineret, a treatment for rheumatoid arthritis, in the United States.

When a devastating earthquake hit Haiti in 2010, Holy Name Medical Center was in a good position to help, as over the past two decades, it has built a presence at Hopital Sacre Coeur, in Milot, about a four-hour drive from Port-au-Prince.

Gov. Chris Christie today issued a letter to Kathleen Sebilieus, the secretary of health and human services, declaring New Jersey will opt to have a federally run health insurance exchange, instead of a partnership with the federal government.

An entrepreneurial group of New Jersey Institute of Technology undergraduate students is one step closer to patenting and marketing painless needle technology after securing $6,000 in seed capital by winning two recent contests sponsored by Capital One Bank.

In a meeting of its board today, the New Jersey Economic Development Authority moved to help businesses hurt by Hurricane Sandy and also created a new accelerator for life sciences and health care information technology firms.

It's no secret that New Jersey has some of the highest health care costs in the nation, and according to a recent report, that applies even more so for care delivered outside of insurance contracts.

One of the largest changes promised by the Affordable Care Act — how doctors and hospitals are reimbursed — is now being put into practice.